We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,557 results
  1. Long-acting injectable paliperidone palmitate induced severe cutaneous allergic reaction in a patient with first episode delusional disorder tolerating oral paliperidone regimen: a case report

    Background

    Paliperidone is a second-generation antipsychotic agent that is effective in the treatment of schizophrenia and schizoaffective disorder as...

    Natasa Borojevic, Midya Dawud, ... Yang Yun in BMC Psychiatry
    Article Open access 24 November 2022
  2. Paliperidone palmitate vs. paliperidone extended-release for the acute treatment of adults with schizophrenia: a systematic review and pairwise and network meta-analysis

    Is paliperidone palmitate (PP) a useful treatment option for adults with acute symptoms of schizophrenia? We conducted a systematic review and a...

    Taro Kishi, Kenji Sakuma, Nakao Iwata in Translational Psychiatry
    Article Open access 19 December 2022
  3. Paliperidone

    Article 20 April 2024
  4. Paliperidone

    Article 08 June 2024
  5. Paliperidone

    Article 25 May 2024
  6. Paliperidone

    Article 22 June 2024
  7. Paliperidone

    Article 01 June 2024
  8. Paliperidone

    Article 16 March 2024
  9. Paliperidone

    Article 04 November 2023
  10. Paliperidone

    Article 06 April 2024
  11. Health economics study of paliperidone palmitate in the treatment of schizophrenia: a 12-month cohort study

    Background

    To analyze the economic benefits of paliperidone palmitate in the treatment of schizophrenia.

    Methods

    We collected 546 patients who met the...

    **ng Luo, Fang Liu, ... Jicai Wang in BMC Psychiatry
    Article Open access 12 June 2024
  12. Paliperidone

    Article 25 May 2024
  13. Factors Associated with Symptom Stabilization that Allow for Successful Transition from Once-Monthly Paliperidone Palmitate to Three-Monthly Paliperidone Palmitate: A Post Hoc Analysis Examined Clinical Characteristics in Chinese Patients with Schizophrenia

    Background and Objectives

    Identifying key factors for a successful transition from once-monthly paliperidone palmitate (PP1M) to three-monthly...

    **n Li, Chong Ye, ... Gang Wang in CNS Drugs
    Article Open access 08 January 2024
  14. Paliperidone

    Article 09 December 2023
  15. Paliperidone

    Article 21 October 2023
  16. Paliperidone

    Article 14 October 2023
Did you find what you were looking for? Share feedback.